Shanghai Win Win Biotechnology Co., Ltd.: With innovative scientific research and ELISA kits, we aim to help breakthroughs in life sciences. Shanghai Win Win Biotechnology Co., Ltd. (hereinafter referred to as "Win Win Biotechnology") has always been committed to providing high-precision and high reliability life science tools and solutions for global researchers. Recently, the company has made another breakthrough in the field of scientific research and detection with its independently developed next-generation ELISA kit series products, injecting new momentum into research institutions and enterprises in fields such as tumor research, immunology, and drug development. Technological innovation has defined a new standard for ELISA detection. ELISA (enzyme-linked immunosorbent assay) technology is one of the core tools in biomedical research, and its sensitivity and specificity directly affect the accuracy of scientific research results. Based on years of technological accumulation, Win Win Biotech has launched more than 30 ELISA kits covering areas such as inflammation factor detection, cell signaling pathway analysis, pathogen antibody screening, etc., fully covering the needs of basic research experiments. Product core advantages: high sensitivity and accuracy: using antibody labeling technology and signal amplification system, detection limit as low as pg level, repeatability error<5%, ensuring data reliability; Flexible adaptability: supports multiple sample types such as serum, plasma, and cell culture supernatant, and adapts to different experimental scenarios; Strict quality control system: Each batch of products has been validated by international standards, providing complete traceability reports to assist in paper publication and application; Customized services: Provide one-on-one solution design for special targets or complex samples to accelerate the scientific research process. Continuously innovating and fulfilling the mission of 'win-win', in response to the rapid development of multi omics research and precision medicine, Win Win Biotech is accelerating the layout of cutting-edge fields such as multi factor joint detection kits and automated detection supporting equipment, and is strategically cooperating with AI data analysis platforms to promote the upgrading of detection technology towards intelligence and high-throughput. The company has simultaneously launched the "Research Assistance Program" to provide free reagent testing and experimental technology support for young scholars in universities, and to assist in the cultivation of Chinese life science talents.